29-03-2022 18:45 via medpagetoday.com

Reduced-Intensity Conditioned Allogeneic HSCT Impresses in Older ALL

(MedPage Today) -- Reduced-intensity conditioned allogeneic hematopoietic stem-cell transplantation (HSCT) yielded "better than expected" survival outcomes for adults with high-risk acute lymphoblastic leukemia (ALL) in first complete remission...
Read more »